Figure 4. 7 miRNA-signature based risk score predicts OS in patients with BC. (A) Univariable and (B) multivariable analyses for the risk score and clinic-pathological features. (C) ROC curves of the 7 miRNA-signature based risk score and clinicopathological characteristics. (D) A nomogram integrates clinicopathological parameters and the risk score.